ATE312352T1 - Hämatologische bestimmung und reagenz - Google Patents

Hämatologische bestimmung und reagenz

Info

Publication number
ATE312352T1
ATE312352T1 AT00991194T AT00991194T ATE312352T1 AT E312352 T1 ATE312352 T1 AT E312352T1 AT 00991194 T AT00991194 T AT 00991194T AT 00991194 T AT00991194 T AT 00991194T AT E312352 T1 ATE312352 T1 AT E312352T1
Authority
AT
Austria
Prior art keywords
factor
reagent
coagulation
activator
body fluid
Prior art date
Application number
AT00991194T
Other languages
English (en)
Inventor
Patrizia Maria Gempeler
Andreas Calatzis
Original Assignee
Pentapharm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentapharm Ag filed Critical Pentapharm Ag
Application granted granted Critical
Publication of ATE312352T1 publication Critical patent/ATE312352T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
    • G01N2333/4613—Snake venom
    • G01N2333/4616—Snake venom from Russell's viper
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7456—Factor V
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00991194T 1999-12-15 2000-12-14 Hämatologische bestimmung und reagenz ATE312352T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP1999/009952 WO2001044493A2 (en) 1999-12-15 1999-12-15 Hematological assay and reagent
PCT/EP2000/012753 WO2001044819A2 (en) 1999-12-15 2000-12-14 Hematological assay and reagent

Publications (1)

Publication Number Publication Date
ATE312352T1 true ATE312352T1 (de) 2005-12-15

Family

ID=8167528

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00991194T ATE312352T1 (de) 1999-12-15 2000-12-14 Hämatologische bestimmung und reagenz

Country Status (9)

Country Link
US (1) US6994984B2 (de)
EP (1) EP1240528B1 (de)
JP (1) JP4762472B2 (de)
AT (1) ATE312352T1 (de)
AU (2) AU2431800A (de)
CA (1) CA2392350C (de)
DE (1) DE60024669T2 (de)
ES (1) ES2254260T3 (de)
WO (2) WO2001044493A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680177B2 (en) * 2001-12-07 2004-01-20 Cardiovascular Diagnostics, Inc. Low molecular weight heparin assay, system and reagent therefor
US7358337B2 (en) * 2002-08-16 2008-04-15 International Technidyne Corporation Assay for low molecular weight heparin
ES2390271T3 (es) * 2003-09-22 2012-11-08 University Of North Carolina At Chapel Hill Fosfolípidos solubles para uso en ensayos de factores de coagulación
CA2566411A1 (en) * 2004-05-11 2005-11-24 Heptest Laboratories, Inc. Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities
GB2433592A (en) * 2005-12-23 2007-06-27 Pentapharm Ag Assay for thrombin inhibitors
EP1918718A1 (de) * 2006-10-31 2008-05-07 Roche Diagnostics GmbH Verfahren und Vorrichtungen zur elektrochemischen Bestimmung von Faktor Xa-Inhibitoren in Blutproben
EP2333555A1 (de) 2009-12-09 2011-06-15 Siemens Healthcare Diagnostics Products GmbH Heterogener Gerinnungstest
JP2011133396A (ja) * 2009-12-25 2011-07-07 Sysmex Corp 活性化部分トロンボプラスチン時間測定試薬、活性化部分トロンボプラスチン時間測定方法、及び血液凝固抑制物質の有無の判定方法
EP2484775A1 (de) * 2011-02-07 2012-08-08 Siemens Healthcare Diagnostics Products GmbH Heparin-insensitives Verfahren zur Bestimmung von direkten Gerinnungsfaktorinhibitoren
RU2517116C2 (ru) * 2012-07-03 2014-05-27 Государственное бюджетное учреждение Санкт-Петербургский научно-исследовательский институт скорой помощи им. И.И. Джанелидзе Способ оценки состояния свертывающей системы крови у пациентов, находящихся в критическом состоянии
WO2014018777A2 (en) 2012-07-25 2014-01-30 Biogen Idec Ma Inc. Blood factor monitoring assay and uses thereof
ES2680932T3 (es) 2013-05-14 2018-09-11 Struszym, S.L. Métodos de determinación de actividades de los factores de coagulación
WO2015086618A1 (en) 2013-12-09 2015-06-18 Dsm Ip Assets B.V. Identification of anticoagulants in a sample
CA3002250C (en) * 2014-10-23 2024-02-06 Q-Sera Pty Ltd Improved clotting composition
JP6873833B2 (ja) * 2017-06-09 2021-05-19 シスメックス株式会社 血液検体の判定方法、血液検体分析装置及びコンピュータプログラム
US10793327B2 (en) 2017-10-09 2020-10-06 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
CN108982865B (zh) * 2018-08-16 2021-05-11 上海原科实业发展有限公司 一种血栓弹力图法肝素定量检测试剂盒及其制备方法
CN109082458B (zh) * 2018-08-16 2024-02-23 上海原科实业发展有限公司 一种血栓弹力图法定量检测口服凝血因子Xa抑制剂试剂盒及其制备方法
CN109709344A (zh) * 2018-12-29 2019-05-03 贵州金玖生物技术有限公司 一种活化凝血检测试剂、其制备方法及其应用
EP3938742A1 (de) 2019-03-14 2022-01-19 Terumo BCT Biotechnologies, LLC Mehrteiliger lyophilisierungsbehälter und verwendungsverfahren
CN110244066A (zh) * 2019-07-01 2019-09-17 北京乐普医疗科技有限责任公司 一种干式电化学法凝血酶原时间检测卡及制备方法
CN110887970B (zh) * 2019-11-29 2023-10-31 北京赛科希德科技股份有限公司 抽提缓冲液、兔脑抽提液、pt检测试剂及pt检测试剂盒
JPWO2022145477A1 (de) * 2020-12-28 2022-07-07
EP4270010A1 (de) * 2020-12-28 2023-11-01 Fujimori Kogyo Co., Ltd. Verfahren zur beurteilung der blutgerinnungsleistung und verfahren zur inspektion des risikos von thrombosen
CN117098996A (zh) * 2021-03-31 2023-11-21 美国血液技术公司 止血测量装置质量控制制剂
CN114703252B (zh) * 2022-06-02 2022-11-04 深圳市帝迈生物技术有限公司 一种用于检测血浆中水蛭素、比伐卢定、达比加群含量的试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3516579A1 (de) * 1984-11-19 1986-05-22 Boehringer Mannheim Gmbh, 6800 Mannheim Gerinnungstest auf teststreifen
US4756884A (en) * 1985-08-05 1988-07-12 Biotrack, Inc. Capillary flow device
US5164598A (en) * 1985-08-05 1992-11-17 Biotrack Capillary flow device
US4946775A (en) * 1985-09-05 1990-08-07 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
DE3616496A1 (de) * 1986-05-16 1987-11-19 Boehringer Mannheim Gmbh Analyseelement zur bestimmung von gerinnungsparametern
US5110727A (en) * 1987-04-03 1992-05-05 Cardiovascular Diagnostics, Inc. Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities
US6284475B1 (en) * 1997-07-11 2001-09-04 Mount Sinai School Of Medicine Of The City Of New York Assays for diagnosis of thrombophilic disease

Also Published As

Publication number Publication date
DE60024669D1 (de) 2006-01-12
AU2431800A (en) 2001-06-25
AU776845B2 (en) 2004-09-23
US6994984B2 (en) 2006-02-07
CA2392350A1 (en) 2001-06-21
AU3159301A (en) 2001-06-25
DE60024669T2 (de) 2006-09-28
EP1240528A2 (de) 2002-09-18
WO2001044493A2 (en) 2001-06-21
JP4762472B2 (ja) 2011-08-31
WO2001044819A2 (en) 2001-06-21
EP1240528B1 (de) 2005-12-07
CA2392350C (en) 2010-11-02
ES2254260T3 (es) 2006-06-16
WO2001044819A3 (en) 2001-12-06
JP2003517610A (ja) 2003-05-27
US20030104508A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
ATE312352T1 (de) Hämatologische bestimmung und reagenz
Funk et al. Reptilase®‐R—A New Reagent in Blood Coagulation
US7682808B2 (en) Coagulation and fibrinolytic cascades modulator
ES2255121T3 (es) Procedimiento para la determinacion del potencial anticoagulante de una muestra y procedimiento para la determinacion de la glicosilacion de trombomodulina.
ES2072970T3 (es) Metodo para determinar el potencial de trombina endogeno del plasma y de la sangre, y tambien un equipo para su uso en dicho metodo.
JPH0711524B2 (ja) プロトロンビン時間測定用試薬
ES2154703T5 (es) Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada.
ES2043612T3 (es) Procedimiento para la determinacion fotometrica de la actividad de proteina c y/o proteina s.
JP3533012B2 (ja) プロテインｃ／プロテインｓ系の障害を検出する方法
BR9906667A (pt) Processo para a determinação do estado de materiais contendo queratina bem como dispositivos e agentes adequados para este fim
ES2329672T3 (es) Ensayo hematologico y kit.
Bonilla Defibrinating enzyme from timber rattlesnake (Crotalus H. Horridus) venom: A potential agent for therapeutic defibrination I. Purification and properties
SE8501614L (sv) Solubiliserbar, fibrinbaserad komposition och anvendning derav
ATE422555T1 (de) Test für niedrigmolekulares heparin, system und reagenz dafür
Henderson et al. Response of factor VIII and IX-deficient blood to wild type and high membrane affinity mutant factor VIIa in an in vitro whole blood clotting assay: possible correlation to clinical outcome
CA2389747A1 (en) Use of russell's viper venom-induced plasma factor xa activity to monitor the activity of factor xa inhibitors
AU705561B2 (en) Calibrator for use in test methods for detecting a defective coagulation factor V
US5529905A (en) Method of assaying plasma proteins with prothrombin fragments
Kato et al. Automated fluorogenic methods for the evaluation of the extrinsic coagulation reactions in human plasma
DE60225587D1 (de) Protease assay zur kontrolle medikamentöser therapie
ES2217739T3 (es) Prueba de coagulacion de sangre mejorada.
ATE407216T1 (de) Testsystem zur bestimmung von in-vivo aktiven proteasen der hämostase in biologischen flüssigkeiten
JPH04350560A (ja) プロテインｓ活性の機能的測定方法
JP3761925B2 (ja) 安定なプラスミン溶液
ATE463509T1 (de) Stabilisierung von herz-troponin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1240528

Country of ref document: EP

REN Ceased due to non-payment of the annual fee